Johnson & Johnson’s Spravato gets FDA approval for treating depression

The drug is aimed at patients with severe depression who have shown resistance to two antidepressants they have tried. The U.S. Food & Drug Administration (FDA) has recently granted approval for Spravato, the ketamine-derived nasal spr....

Grab seeks more investment after record $4.5B funding round in SE Asia

Grab will look to partner with more companies that can provide complementary technology and services to help grow its business in the region Grab, the ride-hailing company headquartered in Singapore, is reportedly planning to raise more fu....

Our Contributors

Mateen Dalal
Akshay Kedari
« First878889